Biotherapeutics Company To Open A Manufacturing Facility In Melbourne’s North

Biotherapeutics Company To Open A Manufacturing Facility In Melbourne’s North

Victoria Minister for Trade and Investment Philip Dalidakis

New Biotech Facility To Save Lives And Boost Jobs

Victor P Taffa

Leading global biotherapeutics company CSL Limited has unveiled its new world-class manufacturing facility in Melbourne’s north, which will create life-saving medicine and hundreds of jobs.

Minister for Trade and Investment Philip Dalidakis joined Minister for Industry and Employment Ben Carroll at the opening of the $230 Million Broadmeadows facility which will create 200 new full time local jobs.

“This is yet another example of an innovative company investing in Victoria to support our economy and create jobs, and we look forward to continuing to work with CSL well into the future.” Minister for Trade and Investment Philip Dalidakis said.

This facility will manufacture albumin a protein derived from human plasma used in critical care to treat burns and shock.

CSL expects the facility to produce therapies with an estimated annual market value of $850 million with plans to export products to the United States and Europe, while also producing products for the local Australian market.

CSL currently provides life-saving products to more than 60 countries and employs nearly 20,000 people with major facilities in Australia, China, the UK, Germany, Switzerland and the USA.

In Australia, CSL employs more than 2,000 people with 98 % of those in Victoria.

“Not only will this new facility produce life-saving medicine but it will also create hundreds of new jobs for Victoria.” Minister for Industry and Employment Ben Carroll said.

Victoria is a world-leader in the development and manufacture of biotechnology, medical technology, and pharmaceutical products with the recent State of the Sector Medical Technologies and Pharmaceuticals 2017 report showing that pharmaceutical manufacturing in Victoria is booming.

Medtech and pharmaceutical sector currently employs more than 23,000 people, generates over $12.7 Billion in revenue and contributes over $1.35 Billion in exports to the Victorian economy.

Andrews Government is driving jobs, investment and export growth in the medical technology and pharmaceutical sector through the Future Industries Fund.